<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05027503</url>
  </required_header>
  <id_info>
    <org_study_id>IUCbcinar01</org_study_id>
    <nct_id>NCT05027503</nct_id>
  </id_info>
  <brief_title>Effectiveness of the Hippotherapy Simulator in Children With Cystic Fibrosis</brief_title>
  <official_title>Investigation of the Effectiveness of the Hippotherapy Simulator Added to Respiratory Physiotherapy in Children With Cystic Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University-Cerrahpasa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University-Cerrahpasa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cystic fibrosis (CF) is a genetic disease that affects many organs and systems, especially&#xD;
      respiratory system problems due to lung damage. Patients often have difficulty in removing&#xD;
      the sticky and viscous secretion that accumulates in the respiratory tract, and the risk of&#xD;
      mortality increases with the development of respiratory failure. In patients with CF,&#xD;
      exercise capacity, peripheral muscle strength, core endurance, flexibility, postural&#xD;
      stability, physical activity level, and quality of life also decrease secondarily. Recently&#xD;
      published guidelines recommend respiratory physiotherapy for coping with CF-related symptoms&#xD;
      and recommend referral of patients to physical activity and exercise.&#xD;
&#xD;
      Hippotherapy simulator is a mechanical exercise tool that imitates the walking movement of a&#xD;
      real horse and is used to increase physical fitness parameters.&#xD;
&#xD;
      This study aims to show the effects of exercises performed with a hippotherapy simulator in&#xD;
      addition to respiratory physiotherapy on physical fitness, sputum production, physical&#xD;
      activity and quality of life of children with CF.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 19, 2021</start_date>
  <completion_date type="Anticipated">June 19, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 19, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Forced Vital Capacity (FVC)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Pulmonary Function Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forced Expiratory Volume in 1 second (FEV1)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Pulmonary Function Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tiffeneau ratio (FEV1/FVC)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Pulmonary Function Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peak Expiratory Flow (PEF)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Pulmonary Function Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forced mid-expiratory flow rate (FEF 25-75%)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Pulmonary Function Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Distance covered in six minute walk test</measure>
    <time_frame>8 weeks</time_frame>
    <description>Functional Capacity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Amount of sputum expelled (gr)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Sputum amount</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postural stability test score in Biodex Balance System SD</measure>
    <time_frame>8 weeks</time_frame>
    <description>Postural Stability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Limits of stability test score in Biodex Balance System SD</measure>
    <time_frame>8 weeks</time_frame>
    <description>Postural Stability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sit and reach test</measure>
    <time_frame>8 weeks</time_frame>
    <description>Flexibility</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>m. quadriceps strength</measure>
    <time_frame>8 weeks</time_frame>
    <description>Peripheral Muscle Strength</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biering Sorenson Test</measure>
    <time_frame>8 weeks</time_frame>
    <description>Core Muscles Endurance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lateral Bridge Test</measure>
    <time_frame>8 weeks</time_frame>
    <description>Core Muscles Endurance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trunk Flexion Test</measure>
    <time_frame>8 weeks</time_frame>
    <description>Core Muscles Endurance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity Questionnaire for Children (PAQ-C)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Physical Activity Level. As a result of the 9-item questionnaire, 1 means lowest and 5 means highest physical activity level.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cystic Fibrosis Questionnaire Revised (CFQ-R)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Quality of Life Assessment. In this questionnaire, which consists of 35 questions, the total score is 100, and a higher score indicates a better quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sense of chest congestion</measure>
    <time_frame>8 weeks</time_frame>
    <description>Subjective evaluation method questioning &quot;sense of chest congestion&quot; with visual analog scale (0-10 point). A higher score indicates greater sense of chest congestion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ease of expectoration</measure>
    <time_frame>8 weeks</time_frame>
    <description>Subjective assessment that evaluates &quot;how hard the person has during sputum production&quot; with a visual analog scale (0-10 point). A high score means that it is easy to sputum.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Cystic Fibrosis in Children</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Home-based respiratory physiotherapy will be applied twice a day and every day of the week for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Training Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In addition to home-based respiratory physiotherapy, 30 min exercises with the hippotherapy simulator will be done.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise with hippotherapy simulator</intervention_name>
    <description>30-minute (5 min warm-up+20 min exercise+5 min cool-down) center-based exercise with the hippotherapy simulator will be done 2 days a week for 8 weeks.</description>
    <arm_group_label>Training Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Respiratory Physiotherapy</intervention_name>
    <description>Respiratory physiotherapy includes breathing control (5x2), diaphragmatic breathing exercises (5x2), thoracic expansion exercises (5x2), incentive spirometer (5x2), opep device (5x2), postural drainage and percussion and cough improvement techniques (10 min). Home-based respiratory physiotherapy will be applied twice a day and every day of the week for 8 weeks.</description>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_label>Training Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Be in the 8-16 age range&#xD;
&#xD;
          -  To be diagnosed with cystic fibrosis according to the American Cystic Fibrosis&#xD;
             Association consensus report criteria&#xD;
&#xD;
          -  Having mild (FEV1 â‰¥ 70% predictive) lung disease according to the disease severity&#xD;
             classification in the annual report of the American Cystic Fibrosis Society&#xD;
&#xD;
          -  To be able to produce phlegm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contracture or deformity,&#xD;
&#xD;
          -  History of diagnosed orthopedic problems affecting mobility or musculoskeletal surgery&#xD;
&#xD;
          -  History of previous lung or liver transplant&#xD;
&#xD;
          -  Have diagnosed vision, hearing, vestibular or neurological problems that may affect&#xD;
             balance,&#xD;
&#xD;
          -  History of hospitalization in the last 1 month&#xD;
&#xD;
          -  Patients who have participated in any exercise training program in the last 6 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>BetÃ¼l Ã‡Ä±nar</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istanbul University - CerrahpaÅŸa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>BetÃ¼l Ã‡Ä±nar, MSc</last_name>
    <phone>+905327879969</phone>
    <email>betulbirik@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>BetÃ¼l Ã‡Ä±nar, MSc</last_name>
    <phone>+902124531700</phone>
    <phone_ext>4648</phone_ext>
    <email>bcinar@bezmialem.edu.tr</email>
  </overall_contact_backup>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 19, 2021</study_first_submitted>
  <study_first_submitted_qc>August 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 30, 2021</study_first_posted>
  <last_update_submitted>October 14, 2021</last_update_submitted>
  <last_update_submitted_qc>October 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University-Cerrahpasa</investigator_affiliation>
    <investigator_full_name>BetÃ¼l Ã‡Ä±nar</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <keyword>cystic fibrosis</keyword>
  <keyword>hippotherapy simulator</keyword>
  <keyword>pulmonary functions</keyword>
  <keyword>sputum expectoration</keyword>
  <keyword>functional capacity</keyword>
  <keyword>6-Minute Walk Test</keyword>
  <keyword>Postural stability</keyword>
  <keyword>motor performance</keyword>
  <keyword>respiratory physiotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

